-
Sep 13, 2020 10:14 AM IST Discussions between Gilead Sciences and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation.
-
Aug 07, 2020 06:07 PM IST The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.
-
Jul 03, 2020 07:20 PM IST The decision comes just days after the company allocated nearly all of its supply of the antiviral to the United States over the next three months, stirring concerns about availability elsewhere.
-
Jul 03, 2020 01:09 PM IST Hetero Labs and Cipla are the only Indian companies to have received the regulatory approval to market the experimental COVID-19 drug.
-
Jun 13, 2020 04:20 PM IST As per the non-exclusive licensing agreement, Gilead will grant Dr Reddy's Laboratories the right to register and manufacture its investigational Coronavirus drug remdesivir in 127 countries.
-
Jun 08, 2020 09:20 AM IST Such a deal would unite two of the drugmakers at the forefront of the industry's efforts to fight the new coronavirus and could be politically sensitive as governments seek control over potential vaccines or treatments.
-
Jun 04, 2020 10:18 AM IST Gilead Sciences' experimental drug Remdesivir has been found to aid in the recovery of COVID-19 patients.
-
May 30, 2020 12:37 AM IST Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said.
-
May 18, 2020 11:50 AM IST -
May 15, 2020 09:41 PM IST But health access groups say the pacts mean cheaper forms of the drug may not become available in nations seen as non-profitable to the five drugmakers.
-
May 09, 2020 05:25 PM IST In one case, a fake email login page designed to steal passwords was sent in April to a top Gilead executive involved in legal and corporate affairs, according to an archived version on a website used to scan for malicious web addresses.
-
May 07, 2020 09:55 PM IST Japan reached the decision just three days after the US drugmaker filed for fast-track approval for the treatment.
-
May 01, 2020 08:11 AM IST There is a possibility of Indian companies becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).
-
Apr 30, 2020 08:15 PM IST "We're working with the company to emphasize the necessity of speed while at the same time to understand the data," FDA Commissioner Stephen Hahn said.
-
Apr 29, 2020 06:55 PM IST Data from the Commerce Department said gross domestic product fell at a 4.8 percent annualized rate in the January-to-March period, while economists in a Reuters poll were expecting a contraction of 4 percent.
-
Mar 23, 2020 11:30 AM IST Remdesivir has been touted by many - including President Donald Trump - as one of the more promising potential treatments for the virus.
-
Feb 28, 2020 05:23 PM IST Moneycontrol's Shraddha Sharma talks to Prince Thomas to find out what drug companies are doing to find a cure for coronavirus.
-
May 22, 2017 01:36 PM IST Gilead warned that those (generic versions) medicines have not been approved for use in the countries into which they are imported.
-
Dec 15, 2015 12:43 PM IST “The company has received approval for the generic version of ledipasvir + sofosbuvir combination from Drugs Controller General (India)â€, Natco Pharma said in a BSE filing today.
-
Dec 07, 2015 09:28 AM IST According to a press release issued by the Telangana government, Senior Director, South East Asia and Pacific, Aaron Brinkworth and Director, Government Affairs - Asia, Claudio Lilienfeld of Gilead Sciences met Chief Minister K Chandrasekhar Rao in camp office along with their team.
-
Jul 25, 2015 04:02 PM IST The injectable drugs, known as PCSK9 inhibitors, could cost an estimated USD 7,000 to USD 12,000 per year for each person using the drug.
-
May 04, 2015 02:46 PM IST In February this year, Gilead appointed Mylan as its exclusive distributor of Sovaldi in India. Mylan president Rajiv Malik said they have a history of partnering with Gilead to tackle key public health issues in India and around the world, beginning with expanding access to high quality and affordable HIV/AIDS antiretrovirals.
-
Mar 25, 2015 04:17 PM IST The availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said.
-
Mar 24, 2015 03:23 PM IST Shares of Dr Reddy's Laboratories gained 1.7 percent intraday Tuesday on agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.
-
Mar 17, 2015 04:04 PM IST Zydus Cadila had recently signed a non-exclusive licensing agreement with Gilead Sciences to manufacture Sofosbuvir and the fixed dose combination of Ledipasvir/ Sofosbuvir for distribution in 91 developing countries including India.